Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Meridian Bioscience Inc. - Common Stock (NQ:VIVO)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 30, 2023 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	-
Bid (Size)	33.70 (1)
Ask (Size)	33.99 (275)
Prev. Close	33.97
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	43,575,133
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

DoubleVerify To Join S&P SmallCap 600 On January 31 ↗

January 26, 2023

Via Benzinga

Meridian Bioscience's Return On Capital Employed Overview ↗

December 29, 2022

Via Benzinga

Performance

More News

Cannabis Stock Gainers And Losers From December 12, 2022 ↗

December 12, 2022

Via Benzinga

4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire ↗

October 07, 2022

Via The Motley Fool

Silk Road Medical Stock Scores Relative Strength Rating Upgrade ↗

September 28, 2022

Via Investor's Business Daily

Penumbra Stock Hits 80-Plus Relative Strength Rating Benchmark ↗

September 26, 2022

Via Investor's Business Daily

Meridian Bioscience To Be Acquired By SD Biosensor, SJL Partners - Read For How Much ↗

July 07, 2022

Via Benzinga

Looking Into Meridian Bioscience's Return On Capital Employed ↗

August 26, 2022

Via Benzinga

Meridian Bioscience: Q3 Earnings Insights ↗

August 05, 2022

Via Benzinga

Earnings Scheduled For August 5, 2022 ↗

August 05, 2022

Via Benzinga

Preview: Meridian Bioscience's Earnings ↗

August 04, 2022

Via Benzinga

Recap Of Friday's Biotech Catalysts - End of The Day Summary ↗

July 29, 2022

Via Benzinga

Silk Road Medical Stock Clears Key Benchmark, Hitting 90-Plus RS Rating ↗

July 22, 2022

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022 ↗

July 08, 2022

Via Benzinga

MERIDIAN BIOSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Meridian Bioscience, Inc. - VIVO

July 07, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Dear AMC Stock Fans, Mark Your Calendars for Aug. 4 ↗

July 07, 2022

Via InvestorPlace

Meridian Biosciences (VIVO) Stock Trending on $1.5 Billion Buyout Agreement ↗

July 07, 2022

Via InvestorPlace

VIVO Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Meridian Bioscience, Inc. Is Fair to Shareholders

July 07, 2022

From Halper Sadeh LLP

Via Business Wire

Cannabis Stock Gainers And Losers From July 6, 2022 ↗

July 06, 2022

Via Benzinga

Marijuana Stock Movers For June 30, 2022 ↗

June 30, 2022

Via Benzinga

EXCLUSIVE: Has Biotech Bottomed? NYSE Executive Floor Director Says Biogen And These 3 Stocks Look Poised To Outperform ↗

June 30, 2022

Via Benzinga

Cannabis Stock Movers For June 29, 2022 ↗

June 29, 2022

Via Benzinga

Cannabis Stock Movers For June 28, 2022 ↗

June 28, 2022

Via Benzinga

Cannabis Stock Gainers And Losers From June 27, 2022 ↗

June 27, 2022

Via Benzinga

Cannabis Stock Gainers And Losers From June 17, 2022 ↗

June 17, 2022

Via Benzinga

Frequently Asked Questions

Is Meridian Bioscience Inc. - Common Stock publicly traded?

Yes, Meridian Bioscience Inc. - Common Stock is publicly traded.

What exchange does Meridian Bioscience Inc. - Common Stock trade on?

Meridian Bioscience Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Meridian Bioscience Inc. - Common Stock?

The ticker symbol for Meridian Bioscience Inc. - Common Stock is VIVO on the Nasdaq Stock Market

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.